Key facts
- It has raised $111.9M; the latest was PE Growth/Expansion in Jul 2024.
- Notable investors include Temasek Holdings, Gates Foundation, S2G Investments, Fifty Years, AgFunder — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Brightseed
- ·The full record, as it builds
Funding rounds
No funding rounds for Brightseed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Brightseed
Operator of a bioactive company intended to improve the quality of life. The company's platform uses artificial intelligence to discover naturally occurring compounds with proven clinical benefits for health and wellness along with rebalancing human metabolism and exploring the dark matter of the plant kingdom and revealing the powerful compounds found in nature, enabling medical practitioners to reduce risk and ameliorate consequences of chronic diseases and permit individuals to solve the health challenges.
- Sector
- Business Products and Services (B2B)
- HQ
- South San Francisco, CA, United States
- Founded
- 2017
- Employees
- 91
- Website
- brightseedbio.com/
- Ownership
- Privately Held (backing)
Brightseed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brightseed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brightseed in its N-PORT filings yet. We sweep new filings monthly.